Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong
Condition(s):Focal Epilepsy; Generalized Epilepsy; Partial Seizures, SimpleLast Updated:August 27, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Focal Epilepsy; Generalized Epilepsy; Partial Seizures, SimpleLast Updated:August 27, 2020Unknown status
Condition(s):Epilepsy; Partial Onset SeizuresLast Updated:December 31, 2015Completed
Condition(s):EpilepsyLast Updated:April 15, 2022Completed
Condition(s):Epilepsy; Partial Onset SeizuresLast Updated:March 7, 2013Completed
Condition(s):EpilepsyLast Updated:October 12, 2018Completed
Condition(s):SeizuresLast Updated:August 8, 2013Completed
Condition(s):EpilepsyLast Updated:March 23, 2023Completed
Condition(s):EpilepsyLast Updated:May 7, 2019Completed
Condition(s):Partial SeizuresLast Updated:August 25, 2023Completed
Condition(s):Epilepsy; MonotherapyLast Updated:February 2, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.